RNAi-based β-catenin inhibition in combination with MEK inhibition promotes synergistic anti-tumor efficacy and overcomes resistance with MEK inhibition promotes synergistic anti-tumor efficacy and overcomes resistance

被引:0
|
作者
Ganesh, Shanthi
Shui, Serena
Chopda, Girish
Koser, Martin
Craig, Kevin
Dutta, Chaitali
Lai, Cheng
Dudek, Hank
Wang, Weimin
Brown, Bob D.
Abrams, Marc
机构
关键词
D O I
10.1158/1538-7445.AM2017-1229
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
1229
引用
收藏
页数:2
相关论文
共 50 条
  • [31] Combination MEK and mTORC1/2 inhibition overcomes resistance to single agent therapy in pancreatic cancer
    Brown, Wells
    Nemirovsky, Oksana
    Gillespie, Jordan
    McDonald, Paul
    Dedhar, Shoukat
    CANCER RESEARCH, 2020, 80 (16)
  • [32] Synergistic anti-tumor efficacy of doxorubicin and flavopiridol in an in vivo hepatocellular carcinoma model
    Kwak, Min-Sun
    Yu, Su Jong
    Yoon, Jung-Hwan
    Lee, Sung-Hee
    Lee, Soo-Mi
    Lee, Jeong-Hoon
    Kim, Yoon Jun
    Lee, Hyo-Suk
    Kim, Chung Yong
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2015, 141 (11) : 2037 - 2045
  • [33] Synergistic anti-tumor efficacy of doxorubicin and flavopiridol in an in vivo hepatocellular carcinoma model
    Min-Sun Kwak
    Su Jong Yu
    Jung-Hwan Yoon
    Sung-Hee Lee
    Soo-Mi Lee
    Jeong-Hoon Lee
    Yoon Jun Kim
    Hyo-Suk Lee
    Chung Yong Kim
    Journal of Cancer Research and Clinical Oncology, 2015, 141 : 2037 - 2045
  • [34] Ferroptosis Suppressor Protein 1 Inhibition Promotes Tumor Ferroptosis and Anti-tumor Immune Responses in Liver Cancer
    Cheu, Jacinth Wing-Sum
    Lee, Derek
    Li, Qidong
    Goh, Chi Ching
    Bao, Macus Hao-Ran
    Yuen, Vincent Wai-Hin
    Zhang, Misty Shuo
    Yang, Chunxue
    Chan, Cerise Yuen-Ki
    Tse, Aki Pui-Wah
    Sit, Grace Fu-Wan
    Liu, Cindy Xinqi
    Ng, Irene Oi-Lin
    Wong, Chun-Ming
    Wong, Carmen Chak-Lui
    CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY, 2023, 16 (01): : 133 - 159
  • [35] SYNERGISTIC ANTI-TUMOR EFFICACY OF RECOMBINANT TUMOR NECROSIS FACTOR AND CHEMOTHERAPEUTIC-AGENTS INVIVO
    KROSNICK, JA
    MULE, JJ
    ROSENBERG, SA
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 : 432 - 432
  • [36] Inhibition of the Wnt/β-catenin pathway enhances anti-tumor immunity in ovarian cancer
    Doo, D. W.
    Meza-Perez, S.
    Londono, A.
    Boone, J. D.
    Moore, D. J.
    Hudson, C.
    Betella, I.
    Luke, J. J.
    Yang, E. S.
    Birrer, M. J.
    Starenki, D.
    Buchsbaum, D. J.
    Norian, L. A.
    Randall, T.
    Arend, R. C.
    GYNECOLOGIC ONCOLOGY, 2019, 154 : 95 - 95
  • [37] Anti-tumor efficacy of combination integrin αvβ6-targeted photodynamic therapy and immune checkpoint inhibition
    Gao, Liquan
    Zhang, Chenran
    Gao, Duo
    Liu, Hao
    Wang, Fan
    Liu, Zhaofei
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57
  • [38] Anti-BTN1A1 exhibits synergistic anti-tumor immunotherapeutic efficacy in combination with radiation therapy.
    Chung, Ezra
    Kim, Young-Seung
    Park, Andrew
    Lin, Steven H.
    Jung, Hyunjin
    Yoo, Stephen S.
    CANCER RESEARCH, 2022, 82 (12)
  • [39] Synergistic Nanoparticulate Drug Combination Overcomes Multidrug Resistance, Increases Efficacy, and Reduces Cardiotoxicity in a Nonimmunocompromised Breast Tumor Model
    Shuhendler, Adam J.
    Prasad, Preethy
    Zhang, Rui Xue
    Amini, Mohammad Ali
    Sun, Mei
    Liu, Peter P.
    Bristow, Robert G.
    Rauth, Andrew M.
    Wu, Xiao Yu
    MOLECULAR PHARMACEUTICS, 2014, 11 (08) : 2659 - 2674
  • [40] Combination of MEK and autophagy inhibition promotes tumor regression in the KPC mouse model of pancreatic cancer
    Wasko, Urszula N.
    Sastra, Stephen A.
    Palermo, Carmine F.
    Olive, Kenneth P.
    CANCER RESEARCH, 2019, 79 (24)